---
figid: PMC3794713__nihms500992f2
figlink: /pmc/articles/PMC3794713/figure/F2/
number: F2
caption: mTOR and MAPK pathways. Receptor tyrosine kinases (RTKs) activate Ras or
  PI3K. Ras activates the MAPK cascade of Raf (including BRAF), MEK, and ERK kinases,
  leading to cell survival, gene transcription, and proliferation. Activated PI3K
  phosphorylates PIP2 to PIP3 (Phosphatidylinositol bis- and tris- phosphate). PTEN
  dephosphorylates PIP3 to PIP2, inhibiting its signal. PIP3 activates Akt, which
  causes dissociation of TSC2 from TSC1, releasing inhibition of RHEB (Ras Homolog
  Enriched in Brain), which then activates mTORC1. Rapamycin analogues such as everolimus
  inhibit mTOR proteins. Crosstalk between MAPK and PI3K pathways is indicated (Ras/PI3K,
  ERK/mTORC1, and Akt/Raf). Adapted from Gadgeel SM, Wozniak A. Preclinical Rationale
  for PI3K/Akt/mTOR Pathway Inhibitors as Therapy for Epidermal Growth Factor Receptor
  Inhibitor-Resistant Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2013; with permission
  (see also).
pmcid: PMC3794713
papertitle: Translational Research in Endocrine Surgery.
reftext: Scott K. Sherman, et al. Surg Oncol Clin N Am. ;22(4):857-884.
pmc_ranked_result_index: '131482'
pathway_score: 0.9267817
filename: nihms500992f2.jpg
figtitle: mTOR and MAPK pathways
year: ''
organisms: Homo sapiens
ndex: 01dcf1f4-df0c-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3794713__nihms500992f2.html
  '@type': Dataset
  description: mTOR and MAPK pathways. Receptor tyrosine kinases (RTKs) activate Ras
    or PI3K. Ras activates the MAPK cascade of Raf (including BRAF), MEK, and ERK
    kinases, leading to cell survival, gene transcription, and proliferation. Activated
    PI3K phosphorylates PIP2 to PIP3 (Phosphatidylinositol bis- and tris- phosphate).
    PTEN dephosphorylates PIP3 to PIP2, inhibiting its signal. PIP3 activates Akt,
    which causes dissociation of TSC2 from TSC1, releasing inhibition of RHEB (Ras
    Homolog Enriched in Brain), which then activates mTORC1. Rapamycin analogues such
    as everolimus inhibit mTOR proteins. Crosstalk between MAPK and PI3K pathways
    is indicated (Ras/PI3K, ERK/mTORC1, and Akt/Raf). Adapted from Gadgeel SM, Wozniak
    A. Preclinical Rationale for PI3K/Akt/mTOR Pathway Inhibitors as Therapy for Epidermal
    Growth Factor Receptor Inhibitor-Resistant Non-Small-Cell Lung Cancer. Clin Lung
    Cancer. 2013; with permission (see also).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPKAP1
  - MLST8
  - RPTOR
  - MAPK3
  - AKT3
  - RICTOR
  - TSC1
  - AKT1
  - TSC2
  - MAPK1
  - SOS2
  - AKT2
  - SART3
  - MTOR
  - RHEB
  - ARAF
  - RAF1
  - KRAS
  - HRAS
  - MAP2K2
  - PTEN
  - SOS1
  - NRAS
  - GRB2
  - MAP2K1
  - BRAF
  - Glucose
  - Rapamycin
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: TSC1
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: TSC2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: p110
  symbol: p110
  source: hgnc_alias_symbol
  hgnc_symbol: SART3
  entrez: '9733'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: RHEB
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: GRB2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
chemicals:
- word: Glucose
  source: MESH
  identifier: D005947
- word: Rapamycin
  source: MESH
  identifier: D020123
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC3794713__F2
redirect_from: /figures/PMC3794713__F2
figtype: Figure
---
